Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints

Detalles Bibliográficos
Autores principales:	Bafadhel, M, Sciurba, F, Paggiaro, P, Pavord, I, Chapman, K, Yancey, S, Rubin, D, Mayer, B, Harris, S, Bradford, E
Formato:	Conference item
Publicado:	American Thoracic Society 2018

Ejemplares similares